Hualan Biological Engineering Inc. (SHE:002007)
China
· Delayed Price · Currency is CNY 14.54
+0.07 (0.48%)
Apr 29, 2026, 3:04 PM CST
SHE:002007 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 4,479 | 4,584 | 4,366 | 5,333 | 4,503 | 4,426 | Upgrade
|
| Other Revenue | 10.93 | 10.93 | 13.58 | 8.9 | 13.67 | 10.31 | Upgrade
|
| Revenue | 4,490 | 4,595 | 4,379 | 5,342 | 4,517 | 4,436 | Upgrade
|
| Revenue Growth (YoY) | 0.67% | 4.93% | -18.02% | 18.26% | 1.82% | -11.69% | Upgrade
|
| Cost of Revenue | 2,013 | 2,013 | 1,768 | 1,727 | 1,699 | 1,538 | Upgrade
|
| Gross Profit | 2,476 | 2,582 | 2,611 | 3,615 | 2,818 | 2,898 | Upgrade
|
| Selling, General & Admin | 1,035 | 1,040 | 1,066 | 1,465 | 1,205 | 1,011 | Upgrade
|
| Research & Development | 330.51 | 337.46 | 333.18 | 280.84 | 314.7 | 253.63 | Upgrade
|
| Other Operating Expenses | 51.93 | 41.46 | 38.35 | 44.62 | 41.75 | 36.17 | Upgrade
|
| Operating Expenses | 1,442 | 1,453 | 1,432 | 1,805 | 1,595 | 1,312 | Upgrade
|
| Operating Income | 1,034 | 1,130 | 1,179 | 1,810 | 1,223 | 1,586 | Upgrade
|
| Interest Expense | -7.6 | -10.24 | -12.95 | -13.17 | -30.27 | -21.72 | Upgrade
|
| Interest & Investment Income | 66.06 | 72.59 | 157.95 | 164.47 | 128.92 | 85.28 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.25 | 0.25 | -0.15 | -0.3 | -0.01 | 0.33 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.2 | -0.55 | -0.49 | -0.28 | -0.38 | -0.34 | Upgrade
|
| EBT Excluding Unusual Items | 1,096 | 1,192 | 1,323 | 1,961 | 1,322 | 1,650 | Upgrade
|
| Gain (Loss) on Sale of Investments | 13.79 | 15.17 | 32.94 | 60.54 | 36.11 | 26.86 | Upgrade
|
| Gain (Loss) on Sale of Assets | 2.59 | 2.89 | 0.08 | 44.44 | 47.67 | 0.42 | Upgrade
|
| Asset Writedown | -4.37 | -3.53 | -5.71 | -9.71 | -1.19 | -3.23 | Upgrade
|
| Other Unusual Items | -29.61 | -32.77 | -11.81 | 21.24 | 24.17 | 14.39 | Upgrade
|
| Pretax Income | 1,078 | 1,173 | 1,339 | 2,078 | 1,428 | 1,688 | Upgrade
|
| Income Tax Expense | 159.52 | 173.36 | 183.14 | 315.96 | 180.76 | 234.13 | Upgrade
|
| Earnings From Continuing Operations | 918.76 | 999.99 | 1,155 | 1,762 | 1,248 | 1,454 | Upgrade
|
| Minority Interest in Earnings | -61.14 | -59.59 | -67.62 | -280.11 | -171.34 | -155.22 | Upgrade
|
| Net Income | 857.61 | 940.4 | 1,088 | 1,482 | 1,076 | 1,299 | Upgrade
|
| Net Income to Common | 857.61 | 940.4 | 1,088 | 1,482 | 1,076 | 1,299 | Upgrade
|
| Net Income Growth | -24.72% | -13.55% | -26.57% | 37.66% | -17.14% | -19.48% | Upgrade
|
| Shares Outstanding (Basic) | 1,826 | 1,826 | 1,826 | 1,824 | 1,825 | 1,821 | Upgrade
|
| Shares Outstanding (Diluted) | 1,826 | 1,826 | 1,829 | 1,824 | 1,828 | 1,831 | Upgrade
|
| Shares Change (YoY) | -0.13% | -0.16% | 0.23% | -0.19% | -0.17% | 0.59% | Upgrade
|
| EPS (Basic) | 0.47 | 0.52 | 0.60 | 0.81 | 0.59 | 0.71 | Upgrade
|
| EPS (Diluted) | 0.47 | 0.52 | 0.59 | 0.81 | 0.59 | 0.71 | Upgrade
|
| EPS Growth | -24.62% | -13.41% | -26.75% | 37.92% | -17.00% | -19.95% | Upgrade
|
| Free Cash Flow | 676.24 | 680.65 | 803.92 | 592.43 | 563.36 | 621.15 | Upgrade
|
| Free Cash Flow Per Share | 0.37 | 0.37 | 0.44 | 0.33 | 0.31 | 0.34 | Upgrade
|
| Dividend Per Share | 1.000 | 1.000 | 0.200 | 0.300 | 0.300 | 0.200 | Upgrade
|
| Dividend Growth | 400.00% | 400.00% | -33.33% | - | 50.00% | -33.33% | Upgrade
|
| Gross Margin | 55.16% | 56.19% | 59.62% | 67.67% | 62.38% | 65.33% | Upgrade
|
| Operating Margin | 23.03% | 24.58% | 26.92% | 33.89% | 27.08% | 35.76% | Upgrade
|
| Profit Margin | 19.10% | 20.47% | 24.84% | 27.73% | 23.83% | 29.28% | Upgrade
|
| Free Cash Flow Margin | 15.06% | 14.81% | 18.36% | 11.09% | 12.47% | 14.00% | Upgrade
|
| EBITDA | 1,311 | 1,403 | 1,439 | 2,069 | 1,496 | 1,783 | Upgrade
|
| EBITDA Margin | 29.21% | 30.54% | 32.87% | 38.74% | 33.12% | 40.18% | Upgrade
|
| D&A For EBITDA | 277.24 | 273.88 | 260.46 | 259.05 | 272.5 | 196.39 | Upgrade
|
| EBIT | 1,034 | 1,130 | 1,179 | 1,810 | 1,223 | 1,586 | Upgrade
|
| EBIT Margin | 23.03% | 24.58% | 26.92% | 33.89% | 27.08% | 35.76% | Upgrade
|
| Effective Tax Rate | 14.79% | 14.77% | 13.68% | 15.21% | 12.65% | 13.87% | Upgrade
|
| Revenue as Reported | 4,490 | 4,595 | 4,379 | 5,342 | 4,517 | 4,436 | Upgrade
|
| Advertising Expenses | - | 5.42 | 5.08 | 6.31 | 2.84 | 3.38 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.